Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
IDEX Biometrics ASA 14-Day RSI Related Terms
OSL:IDEX vs UBER, SHOP, CRM: 14-Day RSI Comparison
For the Software - Application subindustry, IDEX Biometrics ASA's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IDEX Biometrics ASA 14-Day RSI vs Software Industry
For the Software industry and Technology sector, IDEX Biometrics ASA's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where IDEX Biometrics ASA's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IDEX Biometrics ASA (OSL:IDEX) has a 14-Day RSI of 49.35 as of Jul. 14, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on IDEX Biometrics ASA and its competitors. According to the industry distribution chart, IDEX Biometrics ASA ranks #1614 out of 2930 companies in the Software industry, placing it in the top 55.1%.
Is IDEX Biometrics ASA's 14-Day RSI too high?
IDEX Biometrics ASA's current 14-Day RSI is 49.35. The Software industry median 14-Day RSI is 47.63. IDEX Biometrics ASA's value of 49.35 is 3.6% above this industry median. Based on the distribution chart, IDEX Biometrics ASA ranks #1614 out of 2930 companies in the Software industry, which is below the industry midpoint. Overall, IDEX Biometrics ASA has a GF Score™ of 20/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does IDEX Biometrics ASA's 14-Day RSI compare to UBER and SHOP?
According to the Software industry distribution chart, IDEX Biometrics ASA ranks #1614 out of 2930 companies for 14-Day RSI. This places IDEX Biometrics ASA in the lower half of its industry. The industry median 14-Day RSI is 47.63. IDEX Biometrics ASA's value of 49.35 is 3.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Software company?
The median 14-Day RSI among Software companies is 47.63, based on 2,930 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IDEX Biometrics ASA's current 14-Day RSI of 49.35 is 3.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on IDEX Biometrics ASA and its competitors. For the Software industry, the median 14-Day RSI is 47.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IDEX Biometrics ASA's current 14-Day RSI is 49.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDEX Biometrics ASA stock overvalued right now?
Based on GuruFocus' analysis, IDEX Biometrics ASA (OSL:IDEX) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.53, compared to a current price of kr8.10 — trading 1428.3% above its estimated fair value. The current 14-Day RSI is 49.35 and 3.6% above the Software industry median of 47.63. IDEX Biometrics ASA's overall GF Score™ is 20/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For IDEX Biometrics ASA (OSL:IDEX), the current 14-Day RSI is 49.35 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IDEX Biometrics ASA (OSL:IDEX) Overvalued in 2026?
Based on GuruFocus' analysis, IDEX Biometrics ASA stock appears to be overvalued.
The current stock price of kr8.10 is trading 1428.3% above its estimated GF Value™ of kr0.53.
GuruFocus considers IDEX Biometrics ASA to be Significantly Overvalued.
Key valuation signals for OSL:IDEX:
14-Day RSI: 49.35
GF Value™: kr0.53 vs. price of kr8.10 (1428.3% above fair value)
Industry Position: 3.6% above the Software median (#1614 of 2930)
No single metric tells the full story. See the OSL:IDEX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IDEX Biometrics ASA develops and manufactures fingerprint biometric cards for access control, digital identity, and payment. Its products use fingerprint biometrics for user authentication and are designed for physical and digital access applications. The company serves banks, enterprises, and public sector organizations through direct sales and channel partners.
20GF Score
Get the complete analysis for OSL:IDEX
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSL:IDEX has been successfully added to your 
